J7351 | Injection, bimatoprost, intracameral implant, 1 microgram |
J7355 | Injection, travoprost, intracameral implant, 1 microgram |
C1766 | Introducer/sheath, guiding, intracardiac electrophysiological, steerable, other than peel-away |
C1892 | Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, peel-away |
C1893 | Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away |
C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
C9604 | Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of drug-eluting intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel |
C1754 | Catheter, intradiscal |
A7049 | Expiratory positive airway pressure intranasal resistance valve |
C1780 | Lens, intraocular (new technology) |
C1840 | Lens, intraocular (telescopic) |
V2787 | Astigmatism correcting function of intraocular lens |
V2632 | Posterior chamber intraocular lens |
V2788 | Presbyopia correcting function of intraocular lens |
V2631 | Iris supported intraocular lens |
E0481 | Intrapulmonary percussive ventilation system and related accessories |
C1755 | Catheter, intraspinal |
J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
Q9974 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg |
J0476 | Injection, baclofen, 50 mcg for intrathecal trial |
K1012 | Charger and base station for intraurethral activation device, replacement only |
C9487 | Ustekinumab, for intravenous injection, 1 mg |
J1602 | Injection, golimumab, 1 mg, for intravenous use |
J3358 | Ustekinumab, for intravenous injection, 1 mg |
Q9989 | Ustekinumab, for intravenous injection, 1 mg |
J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg |
M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring |
M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring |
M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring |
J2354 | Injection, octreotide, non-depot form for subcutaneous or intravenous injection, 25 mcg |
J9030 | Bcg live intravesical instillation, 1 mg |
J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg |